Allspring Global Investments Holdings LLC Has $9.63 Million Stock Holdings in Maximus, Inc. $MMS

Allspring Global Investments Holdings LLC decreased its position in shares of Maximus, Inc. (NYSE:MMS) by 63.0% during the 1st quarter, Holdings Channel reports. The institutional investor owned 154,017 shares of the health services provider’s stock after selling 261,859 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Maximus were worth $9,635,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new stake in Maximus in the 4th quarter worth about $60,393,000. River Road Asset Management LLC grew its position in shares of Maximus by 236.1% during the 4th quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock worth $71,064,000 after purchasing an additional 578,326 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Maximus by 218.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider’s stock worth $50,379,000 after purchasing an additional 400,315 shares during the period. Boston Partners increased its holdings in shares of Maximus by 47.0% during the third quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after purchasing an additional 308,892 shares during the period. Finally, The Manufacturers Life Insurance Company raised its position in shares of Maximus by 493.0% in the fourth quarter. The Manufacturers Life Insurance Company now owns 342,266 shares of the health services provider’s stock valued at $29,544,000 after buying an additional 284,548 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on MMS. Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Finally, Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Maximus has an average rating of “Hold”.

Maximus Stock Performance

NYSE MMS opened at $57.52 on Thursday. The firm’s 50 day simple moving average is $58.61 and its 200 day simple moving average is $70.07. The firm has a market capitalization of $3.02 billion, a price-to-earnings ratio of 8.61 and a beta of 0.60. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. Maximus, Inc. has a 1 year low of $52.73 and a 1 year high of $100.00.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, beating the consensus estimate of $1.98 by $0.09. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The business had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. During the same period in the previous year, the business earned $2.01 earnings per share. The company’s revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, research analysts expect that Maximus, Inc. will post 8.43 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be issued a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.3%. Maximus’s payout ratio is 19.76%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.